Meeting
2021 ASCO Annual Meeting
Evaluating the role of aromatase inhibitors (AIs) in the treatment of endometrial stromal sarcomas (ESS).
Authors
Fionnuala Crowley
Mount Sinai Morningside and West, New York, NY
Fionnuala Crowley , Karen Anne Cadoo , Sarah Chiang , Jennifer Jean Mueller , Martee Leigh Hensley , Roisin Eilish O'Cearbhaill
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gynecologic Cancer
Track
Gynecologic Cancer
Sub Track
Uterine Cancer
Citation
J Clin Oncol 39, 2021 (suppl 15; abstr 5575)
DOI
10.1200/JCO.2021.39.15_suppl.5575
Abstract #
5575
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2012 Breast Cancer Symposium
Vascular toxicities of endocrine therapy in early-stage breast cancer: Encouraging observations in a nontrial setting.
First Author: Susan Dent
Poster
2022 ASCO Annual Meeting
A phase 3, single arm, open-label study evaluating ovarian suppression following 3-month leuprolide acetate for injectable suspension in combination with endocrine therapy in premenopausal subjects with HR+, HER2-negative breast cancer (OVELIA).
First Author: Ryan Tooker
Poster
2023 ASCO Annual Meeting
Evolving adjuvant estrogen therapy prescribing among breast oncology workforce.
First Author: Kayla Polcari
Poster
2022 ASCO Annual Meeting
Aromatase inhibitors for breast cancer therapy: Analysis of real-world FAERS data.
First Author: Dawood Findakly